Defunct Company
Total Trials
10
As Lead Sponsor
0
As Collaborator
Total Enrollment
4,394
NCT00265850
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase: Phase 3
Role: Collaborator
Start: Nov 30, 2005
Completion: Jan 31, 2018
NCT00765661
Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients
Phase: Phase 2
Start: Sep 30, 2008
Completion: Feb 28, 2010
NCT00772148
Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients
Start: Oct 31, 2008
Completion: May 31, 2010
NCT00901914
Study of rBet v1 Tablets
Completion: Aug 31, 2009
NCT01229449
Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain Study
Start: Jan 31, 2009
Completion: Sep 30, 2009
NCT01731249
Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis
Start: Nov 30, 2010
Completion: Oct 31, 2012
NCT04176328
Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients
Phase: Phase 1
Start: Oct 25, 2019
Completion: Sep 30, 2020
NCT04208152
A First-in-Human Study of Single and Multiple Doses of anle138b in Healthy Subjects
Start: Dec 6, 2019
Completion: Aug 4, 2020
NCT04685265
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of anle138b in Parkinson's Disease
Start: Dec 22, 2020
Completion: Dec 22, 2022
NCT05532358
A Drug-Drug Interaction Study to Assess the CYP1A2 and CYP3A4 Interaction Potential of TEV-56286 (anle138b)
Start: Sep 12, 2022
Completion: Feb 10, 2023